Palazestrant
Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.Palazestrant inhibits 17b-estradiol (E2), inhibits MCF7 and CAMA-1 cell proliferation, and can be used in breast cancer research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.6
Molecular Formula
C28H36FN3O
Notes
Research use only, not for human use.
Receptor
Estrogen/progestogen Receptor
CAS Number
2092925-89-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal PRMT5 Antibody (RAB-C136) [DyLight 350] - Chimeric](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-20131UV 0.1 mL
Rabbit Monoclonal PRMT5 Antibody (RAB-C136) [DyLight 350] - Chimeric
Ask
View Details 
MBS6400235-01 0.1 mL
CPNE1 (Copine I, Copine-1, COPN1, CPN1, MGC1142) (MaxLight 490)
Ask
View Details MBS6400235-02 5x 0.1 mL
CPNE1 (Copine I, Copine-1, COPN1, CPN1, MGC1142) (MaxLight 490)
Ask
View Details